Julie A. Vetalice, Author at ORTHOWORLD

Spinal Elements Receives FDA 510(k) Clearance for Expandable Interbody Device

Spinal Elements received FDA 510(k) clearance to market a line of expandable interbody fusion devices for posterior, anterior and lateral access to the lumbar spine.

Jun 21, 2016

Centinel Spine Completes Successful Evaluation of STALIF L

ORTHOFLASH Spine

Centinel Spine completed the alpha release and commenced U.S. launch of STALIF L™ No-Profile, a lateral lumbar integrated interbody device.

Jun 21, 2016

SI-BONE Closes $20MM Round of Growth Financing

Investments The Numbers

SI-BONE closed a US $20MM round of growth capital financing. Proceeds will support U.S. sales expansion and R&D to develop new products to treat the SI joint.

Jun 20, 2016

Full Launch of Exactech’s Acapella One Cervical Spacer

ORTHOFLASH Spine

Exactech commenced full launch of the Acapella® One Spacer, a cervical cage pre-assembled with integrated anchors to prevent device migration during anterior cervical fusion.

Jun 20, 2016

First Patient Treated in Microbion’s Phase IIA Orthopaedic Infection Trial

Joint Replacement ORTHOFLASH

Microbion enrolled the first patient in its U.S. Phase IIA study of MBN-101 candidate for treatment of orthopaedic implant-related infections.

Jun 17, 2016

Spineology Launches Elite Expandable Interbody Fusion System

ORTHOFLASH Spine

Spineology released the Elite™ Expandable Interbody Fusion system, designed to be implanted at a minimal height and expanded after final positioning in the disc space.

Jun 17, 2016

OrthoPediatrics Files for $75MM IPO

Investments The Numbers

OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ under the symbol KIDS. Pricing terms were not disclosed.

Jun 17, 2016

Zimmer Biomet Enhances the OSS Orthopedic Salvage System

Joint Replacement ORTHOFLASH

Zimmer Biomet commenced global launch of enhancements to its OSS™ Orthopedic Salvage joint reconstruction prostheses, designed to treat bone loss due to trama, tumor, multiple revision arthroplasties, etc.

Jun 17, 2016